Director of Marketing

Salt Lake City, UT (On-site)

Director/ExecutiveFull time

Posted 2 days ago

Job Summary

Original Job Description

Spend 15 mins, increase your paycheck by $15,000

$15,000 more per year. $45,000 over a 3-year tenure. One practice session with AI. That's the best ROI of any 15 minutes you'll spend this year.

Get Started

ARUP Laboratories logo

ARUP Laboratories

Glassdoor
3.5

ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. A nonprofit enterprise of the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests.With more than 3,000 employees, ARUP offers in excess of 3,000 tests and test combinations, ranging from routine screening tests to highly esoteric molecular and genetic assays.ARUP is an Equal Opportunity Employer M/F/D/V and supports a drug-free environment.Scammers have been posing as ARUP recruiters to target jobseekers using fraudulent email addresses and social media accounts. ARUP recruiters will only contact you with legitimate offers by calling from 800-522-2787 or 801-583-2787 or emailing from an address ending in @aruplab.com. Read our full fraud statement on aruplab.com/careers

Marketing team
Employees
3K
Headquarters
Salt Lake City, Utah, USA
Founded
1984

Traffic Signals

Monthly Visitors
138.9K
Monthly Google Ads Budget
$0.0
Traffic Source Mix
Search
54.1%
Direct
37.7%
Referral
6.4%
Social
1.1%
Paid
0.6%

Headcount Trend

Current headcount: ~3K

Marketing Team

Marketing Roles Posted (Last 30 Days)
2

Funding

Total Funding
$3.0M
Last Raise
3 years ago
Last Raise Amount
$3.0M
  • 2023-01-10
    Grant • $3.0M

Recent News

School of Medicine | University of Utah
MLS Division and ARUP Laboratories Celebrate Opening of Advanced Practice Laboratory
Oct 6, 2025
Labroots
Measles Matters! Understanding the Outbreak and the Lab's Critical Role
Aug 28, 2025
Research and Markets
Skeletal Dysplasia Market Growth Analysis 2025-2030 Featuring BioMarin Pharma, BridgeBio Pharma, Ascendis Pharma, Ipsen, QED Therapeutics and Other Major Players
Aug 12, 2025